BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21726666)

  • 1. A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.
    Lin SY; Dhillon V; Jain S; Chang TT; Hu CT; Lin YJ; Chen SH; Chang KC; Song W; Yu L; Block TM; Su YH
    J Mol Diagn; 2011 Sep; 13(5):474-84. PubMed ID: 21726666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
    Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
    Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes.
    Oh JE; Lim HS; An CH; Jeong EG; Han JY; Lee SH; Yoo NJ
    J Mol Diagn; 2010 Jul; 12(4):418-24. PubMed ID: 20413678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density DNA microarray for detection of most frequent TP53 missense point mutations.
    Rangel-López A; Maldonado-Rodríguez R; Salcedo-Vargas M; Espinosa-Lara JM; Méndez-Tenorio A; Beattie KL
    BMC Biotechnol; 2005 Feb; 5():8. PubMed ID: 15713227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.
    Li J; Wang L; Jänne PA; Makrigiorgos GM
    Clin Chem; 2009 Apr; 55(4):748-56. PubMed ID: 19233916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM; Fu JG; Ge WZ; Zhu JY; Wang JY; Zhang W; Qian W; Huo KK
    J Zhejiang Univ Sci B; 2007 Feb; 8(2):81-7. PubMed ID: 17266182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.
    Kirk GD; Camus-Randon AM; Mendy M; Goedert JJ; Merle P; Trépo C; Bréchot C; Hainaut P; Montesano R
    J Natl Cancer Inst; 2000 Jan; 92(2):148-53. PubMed ID: 10639517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples.
    Song C; Castellanos-Rizaldos E; Bejar R; Ebert BL; Makrigiorgos GM
    Clin Chem; 2015 Nov; 61(11):1354-62. PubMed ID: 26432802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
    Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
    Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer].
    Chen Z; An S; Xie Z; Yan H; Chen J; Su J; Zhang X; Niu F; Guo W; Wu Y
    Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):767-73. PubMed ID: 22008105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High resolution melting for mutation scanning of TP53 exons 5-8.
    Krypuy M; Ahmed AA; Etemadmoghadam D; Hyland SJ; ; DeFazio A; Fox SB; Brenton JD; Bowtell DD; Dobrovic A
    BMC Cancer; 2007 Aug; 7():168. PubMed ID: 17764544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
    Goldblum JR; Bartos RE; Carr KA; Frank TS
    Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced ratio of signals enables digital mutation scanning for rare allele detection.
    Castellanos-Rizaldos E; Paweletz C; Song C; Oxnard GR; Mamon H; Jänne PA; Makrigiorgos GM
    J Mol Diagn; 2015 May; 17(3):284-92. PubMed ID: 25772705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.